Osteoporosis: A review

Clinical Orthopaedics and Related Research

Volumn 425, Issue , 2004, Pages 126-134

  Lin, Julie T ^a   Lane, Joseph M ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CALCIUM CARBONATE; CITRATE CALCIUM; PAMIDRONIC ACID; PARATHYROID HORMONE; PLACEBO; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D; ZOLEDRONIC ACID;

ABDOMINAL PAIN; AWARENESS; BIOMECHANICS; BODY POSTURE; BONE DENSITY; BONE MASS; BONE MINERAL; CONFERENCE PAPER; CONSTIPATION; DIAGNOSTIC IMAGING; DIARRHEA; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM INFLAMMATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ESOPHAGITIS; EXERCISE; FEVER; FLU LIKE SYNDROME; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; METABOLIC BONE DISEASE; MINIMALLY INVASIVE SURGERY; NAUSEA; OSTEOPOROSIS; PERCUTANEOUS VERTEBROPLASTY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; STOMACH ULCER; TAI CHI; TRAINING; VOMITING;

EID: 4043079307     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000132404.30139.f2     Document Type: Conference Paper

References (69)

1. World Health Organization: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1-129, 1994.
2. Avioli LV (ed). The Osteoporotic Syndrome: Detection, prevention, and Treatment. Ed 4. 2000. New York, Academic Press 2000.
3. Beals KA, Brey RA, Gonyou JB: Understanding the female athlete triad: Eating disorders, amenorrhea, and osteoporosis. J Sch Health 69:337-340, 1999.
4. Black DM, Cummings SR, Karpf DB, et al: Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group. Lancet 348:1535-1541, 1996.
5. Black DM, Greenspan SL, Ensrud KE, et al: The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207-1215, 2003.
6. Black DM, Thompson DE, Bauer DC, et al: Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85:4118-4124, 2000.
7. Body JJ, Gaich GA, Scheele WH, et al: A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87:4528-4535, 2002.
8. Cadarette SM, Jaglal SB, Murray TM, et al: Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA 286:57-63, 2001.
9. Cameron ID, Stafford B, Cumming RG, et al: Hip protectors improve falls self-efficacy. Age Ageing 29:57-62, 2000.
10. Chapuy MC, Arlot ME, Delmas PD, et al: Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308:1081-1082, 1994.
11. Chapuy MC, Arlot ME, Duboeuf F, et al: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637-1642, 1992.
12. Chesnut III CH, Silverman S, Andriano K, et al: A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The Prevent Recurrence of Osteoporotic Fractures Study. PROOF Study Group. Am J Med 109:267-276, 2000.
13. Coelho R, Silva C, Maia A, Prata J, Barros H: Bone mineral density and depression: A community study in women. J Psychosom Res 46:29-35, 1999.
14. Cummings SR, Black DM, Nevitt MC, et al: Bone density at various sites for prediction of hip fractures: The Study of Osteoporotic Fractures Research Group. Lancet 341:72-75, 1993.
15. Dempster DW, Cosman F, Kurland ES, et al: Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis; A paired biopsy study. J Bone Miner Res 16:1846-1853, 2001.
16. Dudeney S, Lieberman IH, Reinhardt MK, Hussein M: Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma. J Clin Oncol 20:2382-2387, 2002.
17. Finkelstein JS, Hayes A, Hunzelman JL, et al: The effects of parathyroid hormone, alendronate or both in men with osteoporosis. N Engl J Med 349:1216-1226, 2003.
18. Fogelman I, Ribot C, Smith R, et al: Risedronate reverses bone loss in postmenopausal women with low bone mass: Results from a multinational, double-blind, placebo-controlled trial: BMD-MN Study Group. J Clin Endocrinol Metab 85:1895-1900, 2000.
19. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA: Treatment of osteoporosis: Are physicians missing an opportunity? J Bone Joint Surg 82A:1063-1070, 2000.
20. Gardner MJ, Flik KR, Mooar P, Lane JM: Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg 84A:1342-1348, 2002.
21. Genant HK, Cooper C, Poor G, et al: Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10:259-264, 1999.
22. Gennari C: Analgesic effect of calcitonin in osteoporosis. Bone 30(Suppl 5):67S-70S, 2002.
23. Gold DT, Bales CW, Lyles KW, Drezner MK: Treatment of osteoporosis: The psychological impact of a medical education program on older patients. J Am Geriatr Soc 37:417-422, 1989.
24. Gold DT, Shipp KM, Lyles KW: Managing patients with complications of osteoporosis. Endocrinol Metab Clin North Am 27:485-496, 1998.
25. Guttmann G, Van Linthoudt D: [Efficacy of intravenous pamidronate in osteoporosis, mineralometric evaluation] Schweiz Rundsch Med Prax 88:2057-2060, 1999.
26. Harris ST, Watts NB, Genant HK, et al: Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial: Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344-1352, 1999.
27. Heinemann DF: Osteoporosis: An overview of the National Osteoporosis Foundation clinical practice guide. Geriatrics 55:31-36, 2000.
28. Hubacher M, Wettstein A: Acceptance of hip protectors for hip fracture prevention in nursing homes. Osteoporos Int 12:794-799, 2001.
29. Itoi E, Sinaki M: Effect of back-strengthening exercise on posture in healthy women 49 to 65 years of age. Mayo Clin Proc 69:1054-1059, 1994.
30. Iwamoto J, Takeda T, Ichimura S: Effect of exercise training and detraining on bone mineral density in postmenopausal women with osteoporosis. J Orthop Sci 6:128-132, 2001.
31. Jilka RL, Weinstein RS, Bellido T, et al: Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446, 1999.
32. Kado DM, Browner WS, Palermo L, et al: Vertebral fractures and mortality in older women: A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159:1215-1220, 1999.
33. Kannus P, Parkkari J, Niemi S, et al: Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 343:1506-1513, 2000.
34. Kaplan RS, Sinaki M, Hameister MD: Effect of back supports on back strength in patients with osteoporosis: A pilot study. Mayo Clin Proc 71:235-241, 1996.
35. Kiebzak GM, Beinart GA, Perser K, et al: Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162:2217-2222, 2002.
36. Koivukangas A, Tuukkanen J, Kippo K, et al: Long-term administration of clodronate does not prevent fracture healing in rats. Clin Orthop 268-278, 2003.
37. Kujala UM, Kaprio J, Kannus P, Sarna S, Koskenvuo M: Physical activity and osteoporotic hip fracture risk in men. Arch Intern Med 160:705-708, 2000.
38. Lane JM, Johnson CE, Khan SN, et al: Minimally invasive options for the treatment of osteoporotic vertebral compression fractures. Orthop Clin North Am 33:431-438, 2002.
39. Lane JM, Riley EH, Wirganowicz PZ: Osteoporosis: Diagnosis and treatment. Instr Course Lect 46:445-458, 1997.
40. Lane JM, Russell L, Khan SN: Osteoporosis. Clin Orthop 372:139-150, 2000.
41. Lieberman IH, Dudeney S, Reinhardt MK, Bell G: Initial outcome and efficacy of "kyphoplasty" in the treatment of painful osteoporotic vertebral compression fractures. Spine 26:1631-1638, 2001.
42. Lin JT, Lane JM: Nonmedical management of osteoporosis. Curr Opin Rheumatol 14:441-446, 2002.
43. Lin YC, Wong AM, Chou SW, Tang FT, Wong PY: The effects of Tai Chi Chuan on postural stability in the elderly: Preliminary report. Changgeng Yi Xue Za Zhi 23:197-204, 2000.
44. Lindsay R, Silverman SL, Cooper C, et al: Risk of new vertebral fracture in the year following a fracture. JAMA 285:320-323, 2001.
45. Little DG, Cornell MS, Briody J, et al: Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis: A study in immature rabbits. J Bone Joint Surg 836:1069-1074, 2001.
46. Looker AC, Orwoll ES, Johnston Jr CC, et al: Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761-1768, 1997.
47. Loucks AB, Callister R: Induction and prevention of low-T3 syndrome in exercising women. Am J Physiol 264:R924-R930, 1993.
48. Maricic M, Adachi JD, Sarkar S, et al: Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 162:1140-1143, 2002.
49. Martens MG: Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women: A review. J Reprod Med 48:425-434, 2003.
50. Morello KC, Wurz GT, DeGregorio MW: SERMs: Current status and future trends. Crit Rev Oncol Hematol 43:63-76, 2002.
51. Nakajima A, Shimoji N, Shiomi K, et al: Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17:2038-2047, 2002.
52. Neer RM, Arnaud CD, Zanchetta JR, et al: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441, 2001.
53. Oleksik A, Lips P, Dawson A, et al: Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 15:1384-1392, 2000.
54. Peretz A, Body JJ, Dumon JC, et al: Cyclical pamidronate infusions in postmenopausal osteoporosis. Maturitas 25:69-75, 1996.
55. Reeve J, Meunier PJ, Parsons JA, et al: Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial, BMJ 280:1340-1344, 1980.
56. Reid IR, Brown JP, Burckhardt P, et al: Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653-661, 2002.
57. Riggs BL, Melton III LJ: The worldwide problem of osteoporosis: Insights afforded by epidemiology. Bone 17:505S-511S, 1995.
58. Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333, 2002.
59. Russell-Aulet M, Wang J, Thornton J, Colt EW, Pierson Jr RN: Bone mineral density and mass by total-body dual-photon absorptiometry in normal white and Asian men. J Bone Miner Res 6:1109-1113, 1991.
60. Russell-Aulet M, Wang J, Thornton JC, Colt EW, Pierson Jr RN: Bone mineral density and mass in a cross-sectional study of white and Asian women. J Bone Miner Res 8:575-582, 1993.
61. Sanborn CF, Horea M, Siemers BJ, Dieringer KI: Disordered eating and the female athlete triad. Clin Sports Med 19:199-213, 2000.
62. Silverman SL: Calcitonin. Endocrinol Metab Clin North Am 32:273-284, 2003.
63. Sinaki M, Itoi E, Rogers JW, Bergstrahl EJ, Wahner HW: Correlation of back extensor strength with thoracic kyphosis and lumbar lordosis in estrogen-deficient women. Am J Phys Med Rehabil 75:370-374, 1996.
64. Sinaki M, Itoi E, Wahner HW, et al: Stronger back muscles reduce the incidence of vertebral fractures: A prospective 10 year follow-up of postmenopausal women. Bone 30:836-841, 2002.
65. Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston Jr CC: Predictors of bone mass in perimenopausal women: A prospective study of clinical data using photon absorptiometry. Ann Intern Med 112:96-101, 1990.
66. Snow CM, Shaw JM, Winters KM, Witzke KA: Long-term exercise using weighted vests prevents hip bone loss in postmenopausal women. J Gerontol A Biol Sci Med Sci 55:M489-M491, 2000.
67. Theodorou DJ, Theodorou SJ, Duncan TD, Garfin SR, Wong WH: Percutaneous balloon kyphoplasty for the correction of spinal deformity in painful vertebral body compression fractures. Clin Imaging 26:1-5, 2002.
68. Wolf SL, Barnhart HX, Kutner NG, et al: Reducing frailty and falls in older persons: An investigation of Tai Chi and computerized balance training: Atlanta FICSIT Group: Frailty and Injuries: Cooperative Studies of Intervention Techniques. J Am Geriatr Soc 44:489-497, 1996.
69. Wong AM, Lin YC, Chou SW, Tang FT, Wong PY: Coordination exercise and postural stability in elderly people: Effect of Tai Chi Chuan. Arch Phys Med Rehabil 82:608-612, 2001.